Healthcare Global Enterprises Share Price Today (HCG)
TODAY IN ONE LINE
HCG slumped 5.5% on above-average volume (4.2x avg), lagging Nifty's 0.1% move, with no exchange filing today, suggesting a market-driven move.
With a market cap of ₹9,659.85 Cr., it trades at a P/E of 745.22. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Healthcare Global Enterprises flags
Key strengths and potential risks.
Green Flags
- ●Quarterly OutperformanceLatest quarter Sales up 11.5% and Profit up 162.0%
- ●Healthy Operating MarginsOPM is structurally strong at 18.3%
- ●High Promoter HoldingPromoters hold 64.2% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.01x
- ●FII AccumulationFII holding increased by 1.43% QoQ
- ●Promoter BuyingPromoters increased holdings by 1.32% QoQ
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
Red Flags
- ●Earnings DeclineEPS (TTM) has contracted by 71.2% YoY
- ●Poor Capital ReturnsLow ROE of 2.5%
- ●Expensive ValuationTrading at a high P/E ratio of 690.2x
- ●Rising Receivables vs SalesReceivables grew 35.1% outpacing sales growth of 16.3%
- ●Promoter Pledging DetectedPledge activity recorded on 30-Sep-2025 16:12
What changed recently?
Recent events, corporate actions, and announcements.
Healthcare Global Enterprises Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Healthcare Global Enterprises Limited, framed against the sector median so the premium or discount is obvious at a glance.
Healthcare Global Enterprises Limited trades at a P/E of 745.22× and P/B of 7.69×.
Valuation
Profitability
Growth
Financial Health
Healthcare Global Enterprises Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Healthcare Global Enterprises Limited — derived from the live tape, not yesterday's close.
Healthcare Global Enterprises Limited last traded at ₹646.85 with an intraday range of ₹644–₹688 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹646.85| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 763.23 | +116.38 | +17.99% |
| R3 | 719.23 | +72.38 | +11.19% |
| R2 | 703.62 | +56.77 | +8.78% |
| R1 | 675.23 | +28.38 | +4.39% |
| PIVOT | 659.62 | 12.77 | 1.97% |
| CURRENT | 646.85 | — | — |
| S1 | 631.23 | -15.62 | -2.41% |
| S2 | 615.62 | -31.23 | -4.83% |
| S3 | 587.23 | -59.62 | -9.22% |
| S4 | 543.23 | -103.62 | -16.02% |
HCG is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹676.05–₹688
Trading Below opening range, showing Bearishness
Healthcare Global Enterprises Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Healthcare Global Enterprises Limited, switchable between annual and quarterly views, consolidated or standalone.
Healthcare Global Enterprises Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹9,659.85 Cr. and reported EPS of ₹0.95.
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 831 | 976 | 1,096 | 1,013 | 1,398 | 1,694 | 1,912 | 2,223 | 2,545 |
| Other Income | 13 | 10 | 7 | 17 | 13 | 13 | 17 | 35 | 25 |
| Total Income | 843 | 986 | 1,103 | 1,030 | 1,410 | 1,708 | 1,929 | 2,258 | 2,570 |
| Cost of Goods Sold (COGS) | 190 | 219 | 240 | 240 | 355 | 424 | 475 | 581 | 692 |
| Gross Profit | 641 | 757 | 856 | 773 | 1,043 | 1,270 | 1,437 | 1,642 | 1,853 |
| +Operating Expenses | 522 | 635 | 684 | 647 | 805 | 972 | 1,107 | 1,255 | 1,387 |
| EBITDA | 119 | 123 | 172 | 127 | 238 | 299 | 330 | 387 | 466 |
| +Non-Operating Expenses | 125 | 155 | 286 | 185 | 351 | 267 | 287 | 366 | 376 |
| Profit Before Tax (PBT) | 29 | -22 | -107 | -228 | 89 | 45 | 67 | 56 | 25 |
| +Tax Expense | 10 | -3 | 6 | -8 | 49 | 27 | 26 | 8 | 4 |
| Total Profit for Period | 17 | -31 | -125 | -221 | 39 | 18 | 41 | 49 | 23 |
| Less: Non-controlling Interests | -4 | -6 | -19 | -28 | -15 | -12 | -7 | 4 | 9 |
| Net Profit (Owner's PAT) | 21 | -25 | -107 | -193 | 54 | 29 | 48 | 44 | 14 |
| Earnings Per Share (EPS) | 2.23 | -2.66 | -11.36 | -14.58 | 3.65 | 1.99 | 3.26 | 3.01 | 0.92 |
| Diluted Shares Outstanding (Nos.) | 9 | 9 | 9 | 13 | 15 | 15 | 15 | 15 | 15 |
| +Additional Disclosures | 999 | 1,207 | 1,419 | 1,472 | 1,658 | 2,074 | 2,330 | 2,789 | 3,252 |
| Sales Growth % | — | 17.50 | 12.26 | -7.50 | 37.93 | 21.22 | 12.85 | 16.25 | 14.51 |
| YoY Sales Growth % | — | 17.50 | 12.26 | -7.50 | 37.93 | 21.22 | 12.85 | 16.25 | 14.51 |
| Employee Cost % | 19 | 19 | 19 | 19 | 17 | 16 | 16 | 16 | 15 |
| Other Cost % | 44 | 46 | 43 | 44 | 41 | 41 | 42 | 41 | 40 |
| OPM % | 14 | 13 | 16 | 12 | 17 | 18 | 17 | 17 | 18 |
| Tax % | 36 | 11 | -6 | 3 | 55 | 61 | 39 | 14 | 16 |
| Profit Growth % | — | -220.86 | -330.20 | -81.33 | 127.77 | -45.39 | 64.08 | -7.75 | -69.02 |
| Gross Margin % | 77.16 | 77.60 | 78.11 | 76.29 | 74.61 | 74.97 | 75.14 | 73.88 | 72.80 |
| EBITDA Margin % | 14.30 | 12.56 | 15.72 | 12.49 | 17.03 | 17.63 | 17.24 | 17.42 | 18.30 |
| Interest Coverage Ratio | 1.12 | 0.54 | 0.17 | -0.27 | 0.82 | 1.31 | 1.43 | 1.14 | 1.26 |
| Ebit | 47 | 37 | 24 | -33 | 80 | 135 | 155 | 176 | 222 |
Healthcare Global Enterprises segment analysis: revenue and profit mix.
Disclosed business segments at Healthcare Global Enterprises with their share of revenue and profit, switchable between consolidated and standalone reporting.
Healthcare Global Enterprises discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Healthcare Global Enterprises Limited.
Our AI distills the core fundamental drivers supporting Healthcare Global Enterprises Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Healthcare Global Enterprises Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Quarterly sales grew 11.5% YoY, signaling robust demand for oncology services.
Operating margin 8.73% demonstrates efficient cost management amid sector headwinds.
Promoter holding 64.21% ensures stable long-term ownership and strategic commitment.
Positive operating cash flow ₹192.25 Cr (9M FY26) supports liquidity and sustainability.
EV/EBITDA 25.02x and EV/FCF 3.997x valuations attractive versus healthcare peers.
Key Risks.
Latest quarterly EPS declined 70.5% YoY, indicating severe earnings volatility.
TTM EPS declined 71.2% YoY, reflecting persistent profitability challenges.
ROE 2.55% and ROCE 8.31% critically low versus sector median 14–17%.
Stock trades at P/E 627.91x, severely overvalued relative to sector median.
Net margin 0.54% far below peers' 7–12%, suggesting weak pricing power.
Flip Conditions.
Trim if P/E re-rates above 969. The valuation cushion thins from there.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Healthcare Global Enterprises Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Healthcare Global Enterprises Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Healthcare Global Enterprises Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Healthcare Global Enterprises Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Healthcare Global Enterprises Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Healthcare Global Enterprises Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Healthcare Global Enterprises Limited stood at 80.6% of traded volume, against a 20-day average of 62.8%.
Healthcare Global Enterprises announcements: results, concalls, ratings, M&A.
Filings Healthcare Global Enterprises sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Healthcare Global Enterprises files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 156 documents below.
Shareholders meeting
Healthcare Global Enterprises Limited has submitted the Exchange a copy Srutinizers report dated July 09, 2026 with respect to the resolutions passed…
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Healthcare Global Enterprises Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Trading Window
Healthcare Global Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider…
General Updates
Healthcare Global Enterprises Limited has informed the Exchange that further to the intimation dated May 19, 2026, with respect to the approval of…
Disclosure under SEBI Takeover Regulations
Hector Asia Holdings II Pte. Ltd. has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Investor decks & rating reports.
Healthcare Global Enterprises dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Healthcare Global Enterprises has declared, sequenced by announce and record date.
Healthcare Global Enterprises corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Healthcare Global Enterprises insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Healthcare Global Enterprises as reported to SEBI — buying and selling signals from the people who know the business best.
Healthcare Global Enterprises insider activity below tracks 87 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Bharatsinh S Gadhavi | Insider | 30 Mar 2026 | buy | +13.9 K | ₹72.04 L | ₹519.40 |
| Bharatsinh S Gadhavi | Insider | 30 Mar 2026 | buy | +13.9 K | ₹72.04 L | ₹519.40 |
| Bharatsinh S Gadhavi | Insider | 30 Mar 2026 | buy | +13.9 K | ₹72.04 L | ₹519.40 |
| Bharatsinh S Gadhavi | Insider | 30 Mar 2026 | buy | +13.9 K | ₹72.04 L | ₹519.40 |
| Bharatsinh S Gadhavi | Insider | 30 Mar 2026 | buy | +13.9 K | ₹72.04 L | ₹519.40 |
| Bharatsinh S Gadhavi | Insider | 30 Mar 2026 | buy | +13.9 K | ₹72.04 L | ₹519.40 |
| CATALYST TRUSTEESHIP LIMITED | Insider | 27 Mar 2026 | buy | +14.7 K | ₹75.3 L | ₹512.00 |
| Hector Asia Holdings II Pte. Ltd. | Insider | 27 Mar 2026 | buy | +51.18 L | ₹262.04 Cr. | ₹512.00 |
| AAGNIKA AJAIKUMAR | Insider | 27 Mar 2026 | buy | +19.3 K | ₹98.56 L | ₹512.00 |
| ASMITHA AJAIKUMAR | Insider | 27 Mar 2026 | buy | +19.3 K | ₹98.56 L | ₹512.00 |
About Healthcare Global Enterprises Limited: business, sector, key facts.
What Healthcare Global Enterprises Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Healthcare Global Enterprises Limited operates in the Hospital industry under the Healthcare sector, listed as NSE: HCG, BSE: 539787.
HealthCare Global Enterprises Limited (HCG) is a leading provider of medical and healthcare services in India and internationally, specializing primarily in cancer care and fertility treatments. Their core business model revolves around delivering high-quality medical services across a range of specialties, with a significant focus on these two key areas.
In the realm of cancer care, HCG offers a comprehensive suite of diagnostic and treatment services. This includes radiation therapy, medical oncology (chemotherapy and other medical treatments), and surgical oncology. They also incorporate laboratory services and actively engage in research and development to improve cancer diagnosis, prognosis, and treatment outcomes. This integrated approach aims to provide patients with a holistic and advanced cancer care experience.
HCG's fertility services operate under the Milann brand, a well-established name in the field of reproductive medicine. Milann provides a wide spectrum of treatments, ranging from assisted reproductive technologies (ART) like in-vitro fertilization (IVF) to gynecological endoscopy and fertility preservation services. This comprehensive approach caters to a diverse range of patients' needs within the fertility space.
Beyond cancer and fertility, HCG operates multi-specialty hospitals under the HCG brand. These hospitals provide both inpatient and outpatient services covering a broad array of medical specialties, including cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, pulmonology, and critical care. This diversification allows HCG to offer a wider range of services and potentially attract a larger patient base.
In summary, HCG's business strategy combines specialized expertise in cancer and fertility with a broader multi-specialty hospital network. This diversified approach allows them to cater to a large and diverse patient population across multiple medical needs while maintaining a strong focus on advanced technologies and research to deliver high-quality medical care. Their integrated approach, spanning diagnostics, treatment, and research, positions them as a significant player within the Indian healthcare landscape and beyond.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Top Losers TodayScreener
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
Questions investors ask about Healthcare Global Enterprises Limited (HCG).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Healthcare Global Enterprises Limited (HCG)?
The current share price of Healthcare Global Enterprises Limited (HCG) is ₹646.85. Today, the stock has declined by ₹39.50 (5.76%), trading in a range of ₹644 to ₹688. The stock opened at ₹688 with a trading volume of 12,72,119 shares.
02Is Healthcare Global Enterprises Limited stock a good investment for long-term?
Healthcare Global Enterprises Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹9,659.85 crores, P/E ratio of 745.22, ROE of 2.55%, and ROCE of 8.31%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Healthcare Global Enterprises Limited stock?
The 52-week high price of Healthcare Global Enterprises Limited (HCG) is ₹804.65, while the 52-week low is ₹513.3. Currently trading at ₹646.85, the stock is 45.8% away from its 52-week low and 19.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Healthcare Global Enterprises Limited stock at the current price?
Whether to buy Healthcare Global Enterprises Limited stock at ₹646.85 depends on multiple factors. The stock is currently trading with a P/E ratio of 745.22 and P/B ratio of 7.69. Today's performance shows a loss of 5.76%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Healthcare Global Enterprises Limited and when is the next dividend?
Healthcare Global Enterprises Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹646.85, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Healthcare Global Enterprises Limited?
Healthcare Global Enterprises Limited's key financial metrics include: P/E Ratio: 745.22, P/B Ratio: 7.69, ROE: 2.55%, ROCE: 8.31%, Dividend Yield: 0.00%, EPS: ₹0.95, Book Value: ₹92.07, and Debt-to-Equity: 0.01. The company's market cap stands at ₹9,659.85 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Healthcare Global Enterprises Limited stock performing today in the market?
Healthcare Global Enterprises Limited stock opened at ₹688 and is currently trading at ₹646.85, showing a decline of ₹39.50 (5.76%). The intraday high is ₹688 and low is ₹644. The trading volume stands at 12,72,119 shares, indicating strong market participation today.
08What is the P/E ratio of Healthcare Global Enterprises Limited and what does it indicate?
Healthcare Global Enterprises Limited has a Price-to-Earnings (P/E) ratio of 745.22, which means investors are willing to pay ₹745.22 for every ₹1 of earnings. With an EPS of ₹0.95, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Healthcare Global Enterprises Limited (HCG) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.